Incyte Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Bill Meury
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 3.3yrs |
| Board average tenure | 7yrs |
Recent management updates
Recent updates
CEO
Bill Meury (57 yo)
Mr. William Meury, also known as Bill, is the Chief Executive Officer & Director of Anthos Therapeutics, Inc. since April 2024. He is CEO, President & Director of Incyte Corporation from June 26, 2025. He...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President and Head of Research & Development | 2.2yrs | US$7.90m | 0.0027% € 297.8k | |
| Executive VP & CFO | 6.4yrs | US$5.40m | 0.032% € 3.6m | |
| Advisor to CEO & Director | less than a year | US$17.46m | 0.23% € 25.8m | |
| Executive VP & Chief Medical Officer | 10.3yrs | US$5.98m | 0.0032% € 364.1k | |
| CEO, President & Director | less than a year | no data | no data | |
| VP of Finance | 3.3yrs | no data | 0.0047% € 531.5k | |
| Executive VP & Head of Global Technical Operations | 9.5yrs | no data | 0.028% € 3.1m | |
| Senior Director of Investor Relations | no data | no data | no data | |
| Executive VP | 1.8yrs | no data | 0.00034% € 38.2k | |
| Vice President of Investor Relations & Corporate Communications | no data | no data | no data | |
| Executive Vice President of Human Resources | 22.9yrs | US$1.31m | 0.036% € 4.0m | |
| Executive VP of Global Medical Affairs | no data | US$3.30m | 0.0014% € 161.8k |
Experienced Management: 1INCY's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Advisor to CEO & Director | 11.5yrs | US$17.46m | 0.23% € 25.8m | |
| CEO, President & Director | less than a year | no data | no data | |
| Independent Director | 10.5yrs | US$518.15k | 0.0095% € 1.1m | |
| Independent Chairman of the Board | 23.7yrs | US$552.15k | 0.14% € 16.2m | |
| Independent Director | 3.8yrs | US$494.15k | 0.0045% € 506.8k | |
| Independent Director | 8.5yrs | US$505.65k | 0.0087% € 975.3k | |
| Independent Director | 5.6yrs | US$521.65k | 0.0092% € 1.0m | |
| Independent Director | 5.3yrs | US$494.15k | 0.0056% € 628.1k | |
| Independent Director | 10.5yrs | US$519.15k | 0.011% € 1.2m | |
| Independent Director | 2.8yrs | US$503.88k | 0.0025% € 283.2k |
Experienced Board: 1INCY's board of directors are considered experienced (7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/21 06:28 |
| End of Day Share Price | 2025/07/21 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Incyte Corporation is covered by 54 analysts. 23 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jasper Hellweg | Argus Research Company |
| Thomas Russo | Baird |
| Ishan Majumdar | Baptista Research |